+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Device Outsourcing Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797948
The global medical device outsourcing market size attained a value of USD 105.8 billion in 2022. The market is likely to grow at a CAGR of 11.8% during the forecast period of 2023-2031 to attain a value of USD 288.79 billion by 2031.

Medical Device Outsourcing Market: Introduction

Medical device outsourcing refers to the process where medical device manufacturers or healthcare providers contract with third-party companies or external organizations to perform specific tasks or services related to the development, production, testing, or marketing of medical devices. This practice allows companies to focus on their core competencies, while leveraging the expertise of specialized partners to accomplish various tasks more efficiently and cost-effectively.

Some of the benefits of medical device outsourcing include:

  • Cost savings: Outsourcing can help companies reduce overall costs by leveraging the expertise of specialized partners, who can often perform tasks more efficiently and at a lower cost than in-house resources
  • Access to expertise: By outsourcing specific tasks or services, companies can gain access to specialized knowledge and skill sets that may not be available in-house, enabling them to develop and produce high-quality devices more effectively
  • Improved focus on core competencies: Outsourcing non-core functions allows companies to focus on their primary strengths and competencies, leading to increased efficiency and better allocation of resources
  • Faster time to market: Outsourcing can help companies bring their products to market more quickly by streamlining the development and manufacturing process, leveraging the expertise of partners who have proven track records in their respective fields
  • Risk mitigation: Outsourcing can help companies manage and mitigate risks associated with the development and manufacturing of medical devices by distributing responsibilities and liabilities among multiple partners
  • Scalability and flexibility: Outsourcing allows companies to scale their operations up or down as needed, based on market demand and other factors, without the need for significant investments in infrastructure or personnel
  • Compliance and regulatory support: Outsourcing partners with experience in the medical device industry can help companies navigate complex regulatory requirements and ensure that their products meet all necessary standards and guidelines
  • Enhanced innovation: By working with specialized partners, companies can benefit from their unique insights and innovative approaches, leading to the development of more advanced and effective medical devices

Medical Device Outsourcing Market Segmentations

The market can be categorised into segments, product type, device type, applications, and region.

Market Breakup by Services

  • Quality Assurance
  • Regulatory Affairs Services
  • Product Design and Development Services
  • Product Testing and Sterilization Services
  • Product Implementation Services
  • Product Upgrade Services
  • Product Maintenance Services
  • Raw Material Services
  • Medical Electrical Equipment Services
  • Contract Manufacturing
  • Materials and Chemical Characterization
  • Others

Market Breakup by Product Type

  • Finished Goods
  • Electronics
  • Raw Materials

Market Breakup by Device Type

  • Class-I
  • Class -II
  • Class -III
Global Breakup by Applications
  • Cardiology
  • Diagnostic Imaging
  • Orthopaedic
  • IVD
  • Ophthalmic General
  • Plastic Surgery
  • Drug Delivery
  • Dental
  • Endoscopy
  • Diabetes Care
  • Others

Market Breakup by End User

  • Small Medical Device Company
  • Medium Medical Device Company
  • Large Medical Device Company
  • Others

Medical Device Outsourcing Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Medical Device Outsourcing Market Scenario

The medical device outsourcing market has experienced significant growth in recent years due to the increasing demand for advanced medical devices, rising healthcare costs, and the need for companies to focus on their core competencies. This market expansion is fuelled by the complex regulatory environment, rapid technological advancements, and a growing emphasis on cost-efficiency, which drive medical device manufacturers to seek specialized expertise from external partners.

As a result, the market has seen a surge in service providers offering a wide range of services, such as product design and development, manufacturing, testing, regulatory compliance, and supply chain management. The global market scenario for medical device outsourcing continues to evolve, with emerging markets becoming increasingly attractive destinations for outsourcing due to lower labour costs and the availability of skilled professionals.

Key Players in the Global Medical Device Outsourcing Market

The report gives an in-depth analysis of the key players involved in the medical device outsourcing market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • SGS SA
  • TOXIKON
  • Pace Analytical
  • Intertek Group plc
  • WuXi AppTec
  • North American Science Associates, Inc
  • American Preclinical Services, LLC
  • Sterigenics
  • Charles River Laboratories
  • Celestica Inc
  • Creganna
  • FLEX LTD
  • Heraeus Holding
  • Integer Holdings Corporation
  • Nortech Systems, Inc
  • Plexus Corp
  • Sanmina Corporation
  • EUROFINS SCIENTIFIC
  • TE Connectivity, ICON plc
  • Parexel International Corporation
  • Labcorp Drug Development
  • Tecomet, Inc
  • IQVIA
  • Syneos Health
  • PROVIDIEN LLC.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Medical Device Outsourcing Market Overview
3.1 Global Medical Device Outsourcing Market Historical Value (2016-2022)
3.2 Global Medical Device Outsourcing Market Forecast Value (2023-2031)
4 Global Medical Device Outsourcing Market Landscape
4.1 Global Medical Device Outsourcing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Medical Device Outsourcing Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Medical Device Outsourcing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Medical Device Outsourcing Market Segmentation
6.1 Global Medical Device Outsourcing Market by Services
6.1.1 Market Overview
6.1.2 Quality Assurance
6.1.3 Regulatory Affairs Services
6.1.4 Product Design and Development Services
6.1.5 Product Testing & Sterilization Services
6.1.6 Product Implementation Services
6.1.7 Product Upgrade Services
6.1.8 Product Maintenance Services
6.1.9 Raw Material Services
6.1.10 Medical Electrical Equipment Services
6.1.11 Contract Manufacturing
6.1.12 Materials & Chemical Characterization
6.1.13 Others
6.2 Global Medical Device Outsourcing Market by Product Type
6.2.1 Market Overview
6.2.2 Finished Goods
6.2.3 Electronics
6.2.4 Raw Materials
6.3 Global Medical Device Outsourcing Market by Device Type
6.3.1 Market Overview
6.3.2 Class-I
6.3.3 Class -II
6.3.4 Class -III
6.4 Global Medical Device Outsourcing Market by Applications
6.4.1 Market Overview
6.4.2 Cardiology
6.4.3 Diagnostic Imaging
6.4.4 Orthopedic
6.4.5 IVD
6.4.6 Ophthalmic General
6.4.7 Plastic Surgery
6.4.8 Drug Delivery
6.4.9 Dental
6.4.10 Endoscopy
6.4.11 Diabetes Care
6.4.12 Others
6.5 Global Medical Device Outsourcing Market by End User
6.5.1 Market Overview
6.5.2 Small Medical Device Company
6.5.3 Medium Medical Device Company
6.5.4 Large Medical Device Company
6.5.5 Others
6.6 Global Medical Device Outsourcing Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Medical Device Outsourcing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Medical Device Outsourcing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Medical Device Outsourcing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Medical Device Outsourcing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Medical Device Outsourcing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 SGS SA
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 TOXIKON
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Pace Analytical
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Intertek Group plc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 WuXi AppTec
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 North American Science Associates, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 American Preclinical Services, LLC.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Sterigenics
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Charles River Laboratories
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Celestica Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Creganna
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 FLEX LTD.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Heraeus Holding
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Integer Holdings Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Nortech Systems, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Plexus Corp.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Sanmina Corporation
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 EUROFINS SCIENTIFIC
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 TE Connectivity, ICON plc
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 Parexel International Corporation
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
17.21 Labcorp Drug Development
17.21.1 Financial Analysis
17.21.2 Product Portfolio
17.21.3 Demographic Reach and Achievements
17.21.4 Mergers and Acquisitions
17.21.5 Certifications
17.22 Tecomet, Inc.
17.22.1 Financial Analysis
17.22.2 Product Portfolio
17.22.3 Demographic Reach and Achievements
17.22.4 Mergers and Acquisitions
17.22.5 Certifications
17.23 IQVIA
17.23.1 Financial Analysis
17.23.2 Product Portfolio
17.23.3 Demographic Reach and Achievements
17.23.4 Mergers and Acquisitions
17.23.5 Certifications
17.24 Syneos Health
17.24.1 Financial Analysis
17.24.2 Product Portfolio
17.24.3 Demographic Reach and Achievements
17.24.4 Mergers and Acquisitions
17.24.5 Certifications
17.25 PROVIDIEN LLC.
17.25.1 Financial Analysis
17.25.2 Product Portfolio
17.25.3 Demographic Reach and Achievements
17.25.4 Mergers and Acquisitions
17.25.5 Certifications
18 Global Medical Device Outsourcing Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Sgs Sa
  • Toxikon
  • Pace Analytical
  • Intertek Group plc.
  • Wuxi Apptec
  • North American Science Associates, Inc.
  • American Preclinical Services, LLC.
  • Sterigenics
  • Charles River Laboratories
  • Celestica Inc.
  • Creganna
  • Flex Ltd.
  • Heraeus Holding
  • Integer Holdings Corporation
  • Nortech Systems, Inc.
  • Plexus Corp.
  • Sanmina Corporation
  • Eurofins Scientific
  • Te Connectivity, Icon plc
  • Parexel International Corporation
  • Labcorp Drug Development
  • Tecomet, Inc.
  • Iqvia
  • Syneos Health
  • Providien LLC.

Methodology

Loading
LOADING...

Table Information